
Reset all filters
01 5Gowling WLG (Canada) LLP
02 7Gowling WLG LLP
Reset all filters
01 122747354
Reset all filters
01 7LOTILANER
02 5LOTILANER | MILBEMYCIN OXIME
Reset all filters
01 12TABLET (CHEWABLE)
Reset all filters
01 122029-12-17
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 56.25mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 112.5 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 225 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 450 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 900 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO PLUS
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 56.25mg / 2.11mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO PLUS
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 112.5mg / 4.22mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO PLUS
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 225mg / 8.44mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO PLUS
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 450mg / 16.88mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Brand Name : CREDELIO PLUS
Patent Number : 2747354
Filing Date : 2009-12-17
Strength per Unit : 900mg / 33.75mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2029-12-17
Date Granted : 2016-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF